TYRP1 and melanoma: In an in vitro study using B16-F10 melanoma cells, α-MSH was found to induce a dose-dependent increase in melanin synthesis, tyrosinase activity, and the expression of key melanogenic proteins, including TRP-1, TRP-2, and MITF.